Stock Scorecard

Stock Summary for BioVie Inc - Class A (BIVI) - $3.51 as of 11/20/2024 7:50:10 PM EST

Total Score

10 out of 30

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for BIVI

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for BIVI

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for BIVI

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for BIVI

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for BIVI (28 out of 90)

Stock Price Rating (Max of 10) 3
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 3
Book Value to Price (Max of 10) 1
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0

Latest News for for BIVI

( BIVI ) - Analyzing BioVie's Short Interest - BioVie ( NASDAQ:BIVI ) 10/31/2024 5:15:00 PM
UPDATE -- BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules 10/28/2024 8:10:00 PM
BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - BioVie ( NASDAQ:BIVI ) 10/28/2024 7:13:00 PM
BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules 10/28/2024 7:13:00 PM
BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement 10/24/2024 8:10:00 PM
BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement - BioVie ( NASDAQ:BIVI ) 10/24/2024 8:10:00 PM
BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules - BioVie ( NASDAQ:BIVI ) 10/23/2024 7:24:00 PM
BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules 10/23/2024 7:24:00 PM
Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - iRhythm Technologies ( NASDAQ:IRTC ) 10/22/2024 11:06:00 AM
BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules - BioVie ( NASDAQ:BIVI ) 10/21/2024 7:08:00 PM

Financial Details for BIVI

Company Overview
Ticker BIVI
Company Name BioVie Inc - Class A
Country USA
Description BioVie Inc., a clinical-stage biotechnology company, is dedicated to the discovery, development, and commercialization of drug therapies in the United States. The company is headquartered in Santa Monica, California.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 9/30/2024
Next Earnings Date 2/11/2025

Stock Price History
Last Day Price 3.51
Price 4 Years Ago 173.20
Last Day Price Updated 11/20/2024 7:50:10 PM EST
Last Day Volume 3,523,570
Average Daily Volume 11,478,369
52-Week High 56.54
52-Week Low 1.04
Last Price to 52 Week Low 237.50%

Valuation Measures
Trailing PE N/A
Industry PE 22.60
Sector PE 40.32
5-Year Average PE -11.08
Free Cash Flow Ratio 3.11
Industry Free Cash Flow Ratio 12.03
Sector Free Cash Flow Ratio 27.97
Current Ratio Most Recent Quarter 2.95
Total Cash Per Share 1.13
Book Value Per Share Most Recent Quarter 2.50
Price to Book Ratio 4.43
Industry Price to Book Ratio 5.31
Sector Price to Book Ratio 20.88
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 11.82
Sector Price to Sales Ratio Twelve Trailing Months 7.11
Analyst Buy Ratings N/A
Analyst Strong Buy Ratings N/A

Share Statistics
Total Shares Outstanding 17,768,200
Market Capitalization 62,366,382
Institutional Ownership N/A

Dividends
Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 36.09%
Reported EPS 12 Trailing Months -5.08
Reported EPS Past Year 0.00
Reported EPS Prior Year -1.53
Net Income Twelve Trailing Months -25,562,101
Net Income Past Year -32,120,533
Net Income Prior Year -50,255,815
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 77.79%
Operating Margin Twelve Trailing Months 0.00

Balance Sheet
Total Cash Most Recent Quarter 20,023,405
Total Cash Past Year 23,843,798
Total Cash Prior Year 19,460,883
Net Cash Position Most Recent Quarter 16,673,405
Net Cash Position Past Year -831,156,202
Long Term Debt Past Year 855,000,000
Long Term Debt Prior Year 15,182,344
Total Debt Most Recent Quarter 3,350,000
Equity to Debt Ratio Past Year 0.02
Equity to Debt Ratio Most Recent Quarter 0.81
Total Stockholder Equity Past Year 15,506,215
Total Stockholder Equity Prior Year 15,340,286
Total Stockholder Equity Most Recent Quarter 14,067,085

Free Cash Flow
Free Cash Flow Twelve Trailing Months -19,347,432
Free Cash Flow Per Share Twelve Trailing Months -1.09
Free Cash Flow Past Year -27,945,028
Free Cash Flow Prior Year 0

Options
Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating None

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD 0.28
MACD Signal 0.24
20-Day Bollinger Lower Band 1.01
20-Day Bollinger Middle Band 2.89
20-Day Bollinger Upper Band 4.78
Beta 0.90
RSI 58.54
50-Day SMA 6.22
150-Day SMA 31.93
200-Day SMA 60.19

System
Modified 11/20/2024 7:28:30 PM EST